Statins and outcomes in patients admitted to hospital with community acquired pneumonia: Population based prospective cohort study

British Medical Journal

Volumn 333, Issue 7576, 2006, Pages 999-1001

  Majumdar, Sumit R ^a,b   McAlister, Finlay A ^a   Eurich, Dean T ^a   Padwal, Raj S ^a   Marrie, Thomas J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DRUG USE; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; SEPSIS; TREATMENT OUTCOME; BACTERIAL PNEUMONIA; CANADA; CLINICAL TRIAL; COMMUNICABLE DISEASE; EPIDEMIOLOGY; HOSPITALIZATION; MULTICENTER STUDY; PROSPECTIVE STUDY; REGRESSION ANALYSIS;

AGED; ALBERTA; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEALTHY WORKER EFFECT; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 33750958903     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38992.565972.7C     Document Type: Article

References (20)

1. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients with community acquired pneumonia. Resp Res 2005;6:1-7.
2. Hackam DG, Mamdani M, Li P, Redelmeier DA. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 2006;367:413-8.
3. Fernandez R, De Pedro VJ, Artigas A. Statin therapy prior to ICU admission: protection against infection or a severity marker? Intensive Care Med 2006;32:160-4.
4. Graaf MR, Beiderback AB, Egberts AC, Richel DJ, Guchelaar HJ. The risk of cancer in users of statins. J Clin Oncol 2004;22:2388-94.
5. Wang PS, Solomon DH, Mogun H, Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA. 2000;283:3211-6.
6. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000;356:1627-31.
7. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo controlled trial. Lancet 2002;360:7-22.
8. Cholesterol Treatment Trialists' Collaborators. Efficacy and safety of cholesterol-lowering treatment: meta-analysis of data from 90,506 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
9. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003;158:915-20.
10. Marrie TJ, Wu LL. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 2005;127:1260-70.
11. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2471 patients admitted to hospital with community-acquired pneumonia. Diabetes Care 2005;28:810-5.
12. Basi SK, Marrie TJ, Huang JQ, Majumdar SR. Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes. Am J Med 2004;117:305-11.
13. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia (the CAPITAL study). JAMA 2000;283:749-55.
14. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Singer DE, Coley CM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
15. Rosenbaum PR, Rubin DB. The central role of the propensity score in the comparison of a treatment to a non-randomized control group. Biometrika 1983;70:41-55.
16. Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 2005;28:2345-51.
17. Hosmer DW, Lemeshow S. Assessing the fit of a model. In: Applied logistic regression, 1st ed. New York: Wiley, 1989:140-5.
18. Thomsen RW, Hundborg HH, Johnsen SP, Pedersen L, Sorensen HT, Schonheyder HC, et al. Statin use and mortality within 180 days after bacteremia: a population based cohort study. Crit Care Med 2006;34:1080-6.
19. Pettiti DB. Hormone replacement therapy and heart disease prevention: experimentation trumps observation. JAMA 1998;280:650-2.
20. Thomsen RW, Johnsen SP, Olesen AV, Mortensen JT, Boggild H, Olsen J, et al. Socioeconomic gradient in the use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol 2005;60:534-42.